Showing results (131-140 of 163) with videos related to
Sort By:
Pageof 17
Bioorganic Chemistry|June 27, 2021
Discovery of new quinoxaline-2(1H)-one-based anticancer agents targeting VEGFR-2 as inhibitors: Design, synthesis, and anti-proliferative evaluationKhaled El-Adl, Helmy M Sakr, Reda G Yousef, et al.Plos One|September 23, 2022
Design, synthesis, anti-proliferative evaluation, docking, and MD simulations studies of new thiazolidine-2,4-diones targeting VEGFR-2 and apoptosis pathwayMohammed S Taghour, Hazem Elkady, Wagdy M Eldehna, et al.Future Medicinal Chemistry|November 13, 2023
Discovery of new VEGFR-2 inhibitors and apoptosis inducer-based thieno[2,3-d]pyrimidineSouad A El-Metwally, Hazem Elkady, Mohamed Hagras, et al.Bioorganic Chemistry|August 2, 2021
Discovery of new anticancer thiourea-azetidine hybrids: design, synthesis, in vitro antiproliferative, SAR, in silico molecular docking against VEGFR-2, ADMET, toxicity, and DFT studiesDeepa R Parmar, Jigar Y Soni, Ramakrishna Guduru, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|August 18, 2022
Anti-cancer and immunomodulatory evaluation of new nicotinamide derivatives as potential VEGFR-2 inhibitors and apoptosis inducers: in vitro and in silico studiesReda G Yousef, Alaa Elwan, Ibraheem M M Gobaara, et al.Molecular Diversity|May 10, 2023
New apoptotic anti-triple-negative breast cancer theobromine derivative inhibiting EGFRWT and EGFRT790M: in silico and in vitro evaluationIbrahim H Eissa, Reda G Yousef, Hazem Elkady, et al.Future Medicinal Chemistry|May 8, 2025
Development of new anticancer thiadiazole-sulfonamides as dual EGFR/carbonic anhydrase inhibitorsIbrahim H Eissa, Hazem Elkady, Walid E Elgammal, et al.European Journal of Medicinal Chemistry|August 13, 2017
Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studiesWagdy M Eldehna, Mahmoud F Abo-Ashour, Alessio Nocentini, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|August 24, 2022
Discovery of new 1H-pyrazolo[3,4-d]pyrimidine derivatives as anticancer agents targeting EGFRWT and EGFRT790MAhmed A Gaber, Mohamed Sobhy, Abdallah Turky, et al.Future Medicinal Chemistry|November 18, 2025
Development of novel furan-based VEGFR-2 inhibitors and apoptotic inducers for colorectal cancerEslam B Elkaeed, Maged Mohammed Saleh Al Ward, Hazem Elkady, et al.Pageof 17